BACKGROUND: Depressive symptoms are associated with impaired quality of life (QOL). However, there are scarce data comparing the magnitude of depression on QOL among persons with different chronic diseases in developing countries. This study aimed to evaluate the impact of depression on QOL in patients with ischemic heart disease (IHD) and end-stage renal disease (ESRD) in hemodialysis. METHODS: Cross-sectional survey conducted in 173 patients: 103 with IHD and 70 in hemodialysis. Depression was diagnosed by the Mini International Neuropsychiatric Interview-5.0 and depressive symptoms measured by Beck Depression Inventory. QOL was assessed through the Short-Form-36 (SF-36) and World Health Organization Quality of Life Instrument-brief (WHOQOL-brief). Multivariate analyses were performed to assess the association between variables and QOL. RESULTS: Depression prevalence was 14.3% among IHD patients and 9.9% in the hemodialysis group, and depressive symptoms were present in 39 and 36%, respectively. Regardless of the chronic condition, depressed patients presented lower QOL scores than non-depressed ones in all domains, and the most affected were role emotional, mental health and social functioning of SF-36, and psychological domain of WHOQOL-brief. In linear regression analysis, depressive symptoms were predictive for lower QOL in all domains, with the highest standardized beta coefficients (ranging from -0.26 to -0.64). CONCLUSION: Depression is an independent factor associated with worse QOL in IHD and ESRD patients. Among the priorities aiming at improving QOL must be evaluation and management of depressive symptoms.
BACKGROUND:Depressive symptoms are associated with impaired quality of life (QOL). However, there are scarce data comparing the magnitude of depression on QOL among persons with different chronic diseases in developing countries. This study aimed to evaluate the impact of depression on QOL in patients with ischemic heart disease (IHD) and end-stage renal disease (ESRD) in hemodialysis. METHODS: Cross-sectional survey conducted in 173 patients: 103 with IHD and 70 in hemodialysis. Depression was diagnosed by the Mini International Neuropsychiatric Interview-5.0 and depressive symptoms measured by Beck Depression Inventory. QOL was assessed through the Short-Form-36 (SF-36) and World Health Organization Quality of Life Instrument-brief (WHOQOL-brief). Multivariate analyses were performed to assess the association between variables and QOL. RESULTS:Depression prevalence was 14.3% among IHD patients and 9.9% in the hemodialysis group, and depressive symptoms were present in 39 and 36%, respectively. Regardless of the chronic condition, depressedpatients presented lower QOL scores than non-depressed ones in all domains, and the most affected were role emotional, mental health and social functioning of SF-36, and psychological domain of WHOQOL-brief. In linear regression analysis, depressive symptoms were predictive for lower QOL in all domains, with the highest standardized beta coefficients (ranging from -0.26 to -0.64). CONCLUSION:Depression is an independent factor associated with worse QOL in IHD and ESRDpatients. Among the priorities aiming at improving QOL must be evaluation and management of depressive symptoms.
Authors: D E Bush; R C Ziegelstein; M Tayback; D Richter; S Stevens; H Zahalsky; J A Fauerbach Journal: Am J Cardiol Date: 2001-08-15 Impact factor: 2.778
Authors: John S Rumsfeld; David J Magid; Mary E Plomondon; Anne E Sales; Gary K Grunwald; Nathan R Every; John A Spertus Journal: Am Heart J Date: 2003-03 Impact factor: 4.749
Authors: Antonio Alberto Lopes; Justin M Albert; Eric W Young; Sudtida Satayathum; Ronald L Pisoni; Vittorio E Andreucci; Donna L Mapes; Nancy A Mason; Shunichi Fukuhara; Björn Wikström; Akira Saito; Friedrich K Port Journal: Kidney Int Date: 2004-11 Impact factor: 10.612
Authors: Nina Rieckmann; Ian M Kronish; Donald Haas; William Gerin; William F Chaplin; Matthew M Burg; David Vorchheimer; Karina W Davidson Journal: Am Heart J Date: 2006-11 Impact factor: 4.749
Authors: T E Steele; D Baltimore; S H Finkelstein; P Juergensen; A S Kliger; F O Finkelstein Journal: J Nerv Ment Dis Date: 1996-06 Impact factor: 2.254
Authors: Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley Journal: JAMA Date: 2003-07-09 Impact factor: 56.272
Authors: Luciane N Cruz; Carisi A Polanczyk; Suzi A Camey; Juliana F Hoffmann; Marcelo P Fleck Journal: Qual Life Res Date: 2011-01-29 Impact factor: 4.147
Authors: Linda Y Belayev; Maria K Mor; Mary Ann Sevick; Anne Marie Shields; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Michael J Fine; Steven D Weisbord Journal: Hemodial Int Date: 2014-11-18 Impact factor: 1.812
Authors: Ana Verena Galvão-Castro; Ney Boa-Sorte; Ramon Almeida Kruschewsky; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro Journal: Qual Life Res Date: 2011-11-23 Impact factor: 4.147
Authors: Wim L Loosman; Gertrud L G Haverkamp; Tessa O van den Beukel; Tiny Hoekstra; Friedo W Dekker; Prataap K Chandie Shaw; Yves F C Smets; Louis-Jean Vleming; Pieter M Ter Wee; Carl E H Siegert; Adriaan Honig Journal: J Immigr Minor Health Date: 2018-12
Authors: Julio E Pena-Polanco; Maria K Mor; Fadi A Tohme; Michael J Fine; Paul M Palevsky; Steven D Weisbord Journal: Clin J Am Soc Nephrol Date: 2017-01-26 Impact factor: 8.237
Authors: Ching-Yun Wei; Ruben G W Quek; Guillermo Villa; Shravanthi R Gandra; Carol A Forbes; Steve Ryder; Nigel Armstrong; Sohan Deshpande; Steven Duffy; Jos Kleijnen; Peter Lindgren Journal: Pharmacoeconomics Date: 2017-03 Impact factor: 4.981
Authors: Sônia M H A Araujo; Veralice M S de Bruin; Elizabeth de F Daher; Gilson H Almeida; Camila A M Medeiros; Pedro Felipe C de Bruin Journal: Int Urol Nephrol Date: 2011-07-22 Impact factor: 2.370